Lipid Disorders
Conference Coverage
Coverage denials plague U.S. PCSK9-inhibitor prescriptions
WASHINGTON – A prescription for a PCSK9 inhibitor isn’t likely to be covered.
Conference Coverage
Death watch intensifies for HDL-based interventions
WASHINGTON – The study of HDL cholesterol–based interventions to treat atherosclerotic disease “is on life support.”
Conference Coverage
Coronary flow reserve reveals hidden cardiovascular risk
SNOWMASS, COLO. – Noninvasive tool sheds new light on excess cardiovascular risk in women.
Conference Coverage
Is there clinical benefit to activity trackers?
SAN DIEGO – Wearable activity trackers may help improve patients’ physical fitness, but alone they do not promote physical activity or improve...
From the Journals
Weight fluctuations linked to higher mortality, CV events
Weight fluctuations – like the typical pattern of weight loss followed by partial or total regain that affects most people attempting to lose...
Conference Coverage
Gliflozins’ heart failure protection in type 2 diabetes confirmed
WASHINGTON – Cardioprotection appears to be a class effect of SGLT-2 inhibitors.
Conference Coverage
Hard road disproving that statins make you dumb
Do statins adversely affect mental health? The short answer is “no.”
From the Journals
Osteoarthritis’ link to metabolic syndrome tied to body weight, BMI
Teasing out higher body mass’ effects on the development of OA via increased joint loading and metabolic derangements will require new study...
Conference Coverage
Evolocumab doesn’t make patients dumb
WASHINGTON – Concerns about possible adverse cognitive effects from the new lipid-lowering drug evolocumab and from aggressive lowering of LDL...
Conference Coverage
VIDEO: Evolocumab caused no cognitive issues in FOURIER substudy
WASHINGTON - The PCSK9 inhibitor evolocumab showed no effect on memory or cognition in the EBBINGHAUS substudy of FOURIER.
Conference Coverage
Evolocumab strikes gold in FOURIER trial
WASHINGTON - A PCSK9 inhibitor reduced hard cardiovascular endpoints on top of statin therapy.